Skip to main content
SpringerLink
Log in
Book cover

Sepsis pp 17–24Cite as

Hematological and Coagulation Changes in Sepsis

  • Chapter

  • 2453 Accesses

Part of the book series: Competency-Based Critical Care ((CBCC))

The septic patient poses a particular challenge to the clinician and hematologist because of the numerous ways in which the blood count and coagulation profile may be altered and the dynamic nature of these changes. This chapter summarizes the major ways in which sepsis can alter the blood and outlines areas of controversy in management.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bain BJ. Blood cells: a practical guide. 3rd ed. 2002, Malden, MA, Oxford, Blackwell.

    Google Scholar 

  2. Bilgin K, Yaramis A, Haspolat K, Tas MA, Gunbey S, Derman O. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001;108:1383–1384.

    Google Scholar 

  3. Kocherlakota P, La Gamma EF. Human granu locyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neu-tropenia. Pediatrics 1997;100:E6.

    Article  PubMed  CAS  Google Scholar 

  4. Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003;3:CD003066.

    PubMed  Google Scholar 

  5. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002;30:1765–1771.

    Article  PubMed  Google Scholar 

  6. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000;28:1871–1876.

    Article  PubMed  CAS  Google Scholar 

  7. Nijsten MW, ten Duis HJ, Zijlstra JG, Porte RJ, Zwalveling JH, Paling JC, The TH. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med 2000;28:3843– 3846.

    Article  PubMed  CAS  Google Scholar 

  8. Acka S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002;30:753–756.

    Article  Google Scholar 

  9. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245:295–300.

    Article  PubMed  CAS  Google Scholar 

  10. Valade N, Decailliot F, Rebufat Y, Heurtematte Y, Duvaldestin P, Stephan F. Thrombocytosis after trauma: incidence, aetiology, and clinical signifi-cance. Br J Anaesth 2005;94:18–23.

    Article  PubMed  CAS  Google Scholar 

  11. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic infl ammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg 1999;229:121–127.

    Article  PubMed  CAS  Google Scholar 

  12. Toh CH, Dennis M. Disseminated intravascular coagulation: old disease, new hope. Br Med J 2003;327:974–977.

    Article  Google Scholar 

  13. Dempfl e CE. Coagulopathy of sepsis. Thromb Haemost 2004;91:213–224.

    PubMed  CAS  Google Scholar 

  14. Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med 2003;31:2788–2793.

    Article  PubMed  CAS  Google Scholar 

  15. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria and a scoring system for disseminated intrava-scular coagulation. Thromb Haemost 2001;86:1327–1330.

    PubMed  CAS  Google Scholar 

  16. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10–23.

    Article  Google Scholar 

  17. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11–28.

    Article  Google Scholar 

  18. Wallis JP. Transfusion related acute lung injury (TRALI)-under-diagnosed and under-reported. Br J Anaesth 2003;90:573–576.

    Article  PubMed  CAS  Google Scholar 

  19. Gajic O, Rana R, Mendez JL, Rickman OB, Lymp JF, Hubmayr RD, Moore SB. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004;44:1468–1474.

    Article  PubMed  Google Scholar 

  20. Hebert PC, Wells G, Blajchmann MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409–417.

    Article  PubMed  CAS  Google Scholar 

  21. Tanaka T, Tsujinaka T, Kambayashi J, Higashiyama M, Yokota M, Sakon M, Mori T. The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model. Throm Res 1990;60:321–330.

    Article  CAS  Google Scholar 

  22. Slofstra SH, Van't Veer C, Buurman WA, Reitsma PH, ten Cate H, Spek CA. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med 2005;33:1365–1370.

    Article  PubMed  CAS  Google Scholar 

  23. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor VIIa and anti-thrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996;88:881–886.

    PubMed  CAS  Google Scholar 

  24. Oelschlager C, Romisch J, Staubitz A, Stauss H, Leithauser B, Tillmanns H, Holschermann H. Anti-thrombin III inhibits nuclear factor kappa B activation in human monocytes and vascular endothelial cells. Blood 2002;99:4015–4020.

    Article  PubMed  CAS  Google Scholar 

  25. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286:1869–1878.

    Article  PubMed  CAS  Google Scholar 

  26. de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003;31:1839–1847.

    Article  PubMed  Google Scholar 

  27. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating infl ammation and apoptosis. J Biol Chem 2001;276:11199–11203.

    Article  PubMed  CAS  Google Scholar 

  28. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.

    Article  PubMed  CAS  Google Scholar 

  29. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intra-vascular coagulation. J Thomb Haemost 2004;2:1924–1933.

    Article  CAS  Google Scholar 

  30. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353:1332–1341.

    Article  PubMed  CAS  Google Scholar 

  31. Fourrier F. Recombinant human activated protein C in the treatment of severe sepsis: An evidence-based review. Crit Care Med 2004;32[Suppl.]: S534–S541.

    Article  PubMed  CAS  Google Scholar 

  32. Vincent J-L, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut J-F, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin D, Turlo MA, Janes J. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 2005; 33:2266–2277.

    Article  PubMed  CAS  Google Scholar 

  33. Zenz W, Zoehrer B, Levin M, Fanconi S, Hatzis TD, Knight G, Mullner M, Faust SN. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study. Crit Care Med 2004;32:1777–1780.

    Article  PubMed  CAS  Google Scholar 

  34. Abraham E, Reinhart K, Opal S, Demever I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spagen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein S, Tobias J, Poole L, Stolzenbach JC, Creasey AA. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003;290:256–258.

    Article  Google Scholar 

  35. Stegmayr BG, Banga R, Berggre L, Norda R, Rydvall A, Vikefors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003;31:1730–1736.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Freeman Hospital Newcastle-upon-Tyne, UK

    Tina T. Biss MBBS, MRCP, DIP, FRC Path & J. Wallace-Jonathan MBBS, FRCP(UK), FRC Path

Authors
  1. Tina T. Biss MBBS, MRCP, DIP, FRC Path
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Wallace-Jonathan MBBS, FRCP(UK), FRC Path
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. European Diploma in ITU Royal Victoria Infirmary, University of Newcastle-upon-Tyne Newcastle-upon-Tyne, UK

    Simon V. Baudouin MBBS, MD, FRCP

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Biss, T.T., Wallace-Jonathan, J. (2008). Hematological and Coagulation Changes in Sepsis. In: Baudouin, S.V. (eds) Sepsis. Competency-Based Critical Care. Springer, London. https://doi.org/10.1007/978-1-84628-939-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-939-2_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-938-5

  • Online ISBN: 978-1-84628-939-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation